Hubei Yuancheng Saichuang Technology Co. Ltd
Products
Contact Us
  • Contact Person : Mr. gloria cui
  • Company Name : Hubei Yuancheng Saichuang Technology Co. Ltd
  • Tel : 86-027-50756026
  • Fax : 86-027-68886696
  • Address : hubei,wuhan,No. 496 Zhongshan Road, Wuchang District
  • Country/Region : China
  • Zip : 430064

allopurinol CAS: 315-30-0 skype:ycsclee123)

allopurinol CAS: 315-30-0 skype:ycsclee123)
Product Detailed
Related Categories:Herbal Medicine
allopurinol CAS: 315-30-0 skype:ycsclee123) Key words:allopurinol,CAS: 315-30-0,pharmaceutical Hi!I am gloria, please feel free to contatc me: skype:ycsclee123 ; email:ycgc912 at yccreate dot com;whatsapp:+8613007130937 *.Basic info: product name:allopurinol CAS: 315-30-0 English Synonyms: TIMTEC-BB SBB004202; ISOPURINOL; LABOTEST-BB LT00244764; HPP; 1H-PYRAZOLO [3,4-D] PYRIMIDIN-4-OL; AKOS BBS-00005290; ALLPURINOL; AKOS BBS-00002073 Formula: C5H4N4O Molecular Weight: 136.11 EINECS: 206-250-9 Apperance: white or almost white crystalline powder; almost odorless. Content: 99.8% Quality Standard: usp36 Packing: 25kg / drum Storage methods: shading, sealed and stored in a cool dry place *.Applications: 1.Use of allopurinol and its metabolites do not xanthine, both inhibition of xanthine oxidase interest, and thus make uric acid synthesis is blocked, reducing blood uric acid concentrations, reduce urate calm in the bones, joints and kidneys. Clinical for gout, gouty nephropathy. Pregnant women with caution; Some patients may rash, gastrointestinal reactions and liver damage and hematopoietic systems, such as elevated transaminases and leukopenia; 6 with anticancer drugs - mercaptopurine when combined, to 6 - mercaptopurine dose is reduced to a constant 1/4. More water, in order to facilitate uric acid excretion. 2.Use of anti-gout drugs. For primary or secondary increase in serum uric acid of various diseases, such as gout, acute or chronic leukemia. 3.Use of anti-gout drug, used to treat gout, gouty nephropathy


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.